FR2988295B1 - Composition a base d'eau de mer et d'extraits d'algues a activite anti-vieillissement cutane - Google Patents

Composition a base d'eau de mer et d'extraits d'algues a activite anti-vieillissement cutane

Info

Publication number
FR2988295B1
FR2988295B1 FR1252498A FR1252498A FR2988295B1 FR 2988295 B1 FR2988295 B1 FR 2988295B1 FR 1252498 A FR1252498 A FR 1252498A FR 1252498 A FR1252498 A FR 1252498A FR 2988295 B1 FR2988295 B1 FR 2988295B1
Authority
FR
France
Prior art keywords
skin
algae
aging
sea water
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1252498A
Other languages
English (en)
Other versions
FR2988295A1 (fr
Inventor
Hugues Noel
Daniel Rocher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRES DE BIOLOGIE MARINE DANIEL JOUVANCE
Original Assignee
LABORATOIRES DE BIOLOGIE MARINE DANIEL JOUVANCE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LABORATOIRES DE BIOLOGIE MARINE DANIEL JOUVANCE filed Critical LABORATOIRES DE BIOLOGIE MARINE DANIEL JOUVANCE
Priority to FR1252498A priority Critical patent/FR2988295B1/fr
Publication of FR2988295A1 publication Critical patent/FR2988295A1/fr
Application granted granted Critical
Publication of FR2988295B1 publication Critical patent/FR2988295B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]

Abstract

La présente invention se rapporte à une composition comprenant ou constituée (i) d'eau de mer sélectivement dessalée dont la concentration en chlorure de sodium est inférieure à 10g de NaCI par litre d'eau de mer, associée à (ii) au moins un extrait d'algue unicellulaire du genre tetraselmis, (iii) au moins un polysaccharide choisi parmi les alginates et les acides alginiques, extraits d'algues brunes et/ou d'algues rouges, et (iv) au moins un sel de calcium. Elle concerne également un procédé de traitement cosmétique (i) pour prévenir et/ou retarder et/ou limiter les signes du vieillissement de la peau, et/ou (ii) pour lutter contre les signes du vieillissement cutané et/ou lisser la peau du visage et/ou du corps et/ou traiter les rides et les ridules de la peau et/ou (iii) pour lutter contre la cellulite et/ou la peau d'orange et/ou amincir la silhouette, consistant à appliquer sur la peau une ladite composition.
FR1252498A 2012-03-20 2012-03-20 Composition a base d'eau de mer et d'extraits d'algues a activite anti-vieillissement cutane Expired - Fee Related FR2988295B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1252498A FR2988295B1 (fr) 2012-03-20 2012-03-20 Composition a base d'eau de mer et d'extraits d'algues a activite anti-vieillissement cutane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1252498A FR2988295B1 (fr) 2012-03-20 2012-03-20 Composition a base d'eau de mer et d'extraits d'algues a activite anti-vieillissement cutane

Publications (2)

Publication Number Publication Date
FR2988295A1 FR2988295A1 (fr) 2013-09-27
FR2988295B1 true FR2988295B1 (fr) 2014-04-18

Family

ID=46197484

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1252498A Expired - Fee Related FR2988295B1 (fr) 2012-03-20 2012-03-20 Composition a base d'eau de mer et d'extraits d'algues a activite anti-vieillissement cutane

Country Status (1)

Country Link
FR (1) FR2988295B1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103655304A (zh) * 2013-12-02 2014-03-26 青岛海芬海洋生物科技有限公司 一种含海洋生物成分的祛斑软膜及其制备方法
FR3017051B1 (fr) * 2014-02-05 2017-06-02 Laboratoires De Biologie Marine Daniel Jouvance Composition a base d'eau de mer et d'extraits d'algues et utilisations
FR3052667B1 (fr) * 2016-06-21 2020-03-27 Mirei International Ltd Procede vert d'extraction de bio-actifs de plantes catalyse par l'utilisation de magnesium marin concentre
IT201600124434A1 (it) * 2016-12-07 2018-06-07 Stazione Zoologica Anton Dohrn Estratto grezzo di microalga verde Tetraselmis suecica e suoi usi
FR3117369B1 (fr) 2020-12-11 2023-12-22 Laboratoires De Biologie Vegetale Yves Rocher Utilisation cosmetique d’une association d’extraits de capucine et de tetraselmis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198805A1 (en) * 2003-05-01 2006-09-07 Bioderm Research Cosmetic and Pharmaceutical Masks for Skin Improvement
US20070166266A1 (en) * 2006-01-19 2007-07-19 Solazyme, Inc. Methods and compositions for improving the health and appearance of skin
EP2082755A1 (fr) * 2008-01-16 2009-07-29 CellMed AG Implants in situ d'alginate en réseau monolithiques

Also Published As

Publication number Publication date
FR2988295A1 (fr) 2013-09-27

Similar Documents

Publication Publication Date Title
FR2988295B1 (fr) Composition a base d'eau de mer et d'extraits d'algues a activite anti-vieillissement cutane
ZA202001057B (en) Inhibiting ubiquitin specific peptidase 30
WO2016025635A3 (fr) Polythérapie pour le traitement du cancer
PH12019500845A1 (en) Combinations comprising an ssao/vap-1 inhibitor and a sglt2 inhibitor, uses thereof
MX368248B (es) Gamma-dicetonas para tratamiento y prevencion de piel envejecida y arrugas.
EP2140872A3 (fr) Composition pour le traitement des conditions de la peau contenant de l'eau de mer et du magnesium suppllémentair
MX359626B (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o afecciones asociadas con disfunción mitocondrial.
EP4306542A3 (fr) Traitement de tumeurs positives lag-3
WO2019246262A3 (fr) Procédés de traitement ou d'inhibition de l'apparition de la maladie de huntington
WO2016077632A3 (fr) Inhibition du catabolisme de la proline pour le traitement du cancer et d'autres applications thérapeutiques
WO2011150005A3 (fr) Traitement de maladies associées à l'homologue atonal 1 par inhibition du produit de transcription antisens naturel d'atoh1
WO2007112996A3 (fr) Nouvelle utilisation de composés et de combinaisons de composés pour améliorer l'aspect physique
MX2011009751A (es) Tratamiento de enfermedades relacionadas con factor nuclear (eritroide derivado 2) tipo 2 (nrf2) por inhibicion del transcrito antisentido natural a nrf2.
WO2016043874A3 (fr) Polythérapie pour le traitement du cancer
WO2011082409A3 (fr) Traitement de maladies liées au facteur de régulation de l'interféron 8 (irf8) par l'inhibition du produit de transcription antisens naturel de l'irf8
WO2012009402A3 (fr) Traitement de maladies liées à « discs large homolog » (dlg) par inhibition de transcrit antisens naturel de dlg
WO2008096203A3 (fr) Extraits alimentaires destinés à un traitement contre les anomalies de lipoprotéines et contre les troubles et les maladies de peau
FR2968211B1 (fr) Utilisation d'extrait de levure du genre saccharomyces pour ameliorer l'eclat du teint et composition comprenant au moins cet extrait et un agent depigmentant
MX365366B (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
MX2023002321A (es) Tratamiento de trastornos de perdida de cabello con inhibidores de cinasas asociadas a janus (jak) deuterados.
AU2018282105A1 (en) Dosing of vibegron for treatment of overactive bladder
TW200738255A (en) Methods of regulating renalase (Monoamine Oxidase C)
WO2006034184A3 (fr) Utilisation de modulateurs d'une nouvelle forme de proteine interagissant avec la calcineurine a selectivite musculaire (mcip-1-38) pour le traitement de maladies cardio-vasculaires
WO2016106357A8 (fr) Combinaison d'inhibiteurs de raf et d'inhibiteurs de kinases aurora
MX2017007130A (es) Metodos para el tratamiento de la desregulacion del mejorador de la cadena ligera kappa del factor nuclear de las celulas b activadas (nf-kb) en un organismo hospedero que tenga la necesidad del mismo usando composiciones de la membrana de la cascara del huevo.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20211105